SAT0036 IMPACT OF RHEUMATOID ARTHRITIS IN LIVER DAMAGE. INVOLVEMENT OF ANTI-CITRULLINATED PROTEIN ANTIBODIESI. Arias de la Rosa, N. Barbarroja Puerto, Carmen Torres-Granados et al.|Annals of the Rheumatic Diseases|2019Cited by 2
AB0188 MOLECULAR NETWORKS IN MONOCYTES FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS RELATED TO THEIR PHYSIOPATHOLOGY. MODULATORY EFFECTS OF ANTI-DSDNA ANTIBODIES AND MOLECULAR MECHANISMS UNDERLYING IN VIVOSTATIN TREATMENTA. M. Patiño-Trives, C. López-Pedrera, P. S. Laura et al.|Annals of the Rheumatic Diseases|2019Cited by 0
AB0388 COMPARATIVE EFFECTIVENESS OF RITUXIMAB, TOCILIZUMAB AND TNFI BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS. INFLUENCE OF CLINICAL AND INFLAMMATORY PROFILESC. López-Pedrera, Eduardo Collantes‐Estévez, N. Barbarroja Puerto et al.|Annals of the Rheumatic Diseases|2019Cited by 0
SAT0124 MOLECULAR CHARACTERIZATION OF THE SERUM PROFILE ASSOCIATED TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS. EFFECTS OF BIOLOGICAL DRUGS.C. López-Pedrera, N. Barbarroja Puerto, P. S. Laura et al.|Annals of the Rheumatic Diseases|2019Cited by 0
SAT0037 INCREASED CARDIOMETABOLIC RISK FACTORS ARE RELATED TO THE ABNORMAL ADIPOCYTOKINE PROFILE AND AUTOIMMUNITY IN RHEUMATOID ARTHRITIS. MODULATION BY TNFALPHA AND IL6R INHIBITORSI. Arias de la Rosa, N. Barbarroja Puerto, R. Ortega Castro et al.|Annals of the Rheumatic Diseases|2019Cited by 0